Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | PARP inhibitor tablet for BRCA-mutated ovarian, breast, prostate and pancreatic cancers. | Platinum chemotherapy with less nerve and kidney toxicity than cisplatin. |
| Body system | Cancer | Cancer |
| Drug class | PARP inhibitors | Platinum chemotherapy |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | BRCA-mutated ovarian cancer, BRCA-mutated breast cancer, Prostate cancer (HRR-mutated), Pancreatic cancer | Ovarian cancer, Lung cancer, Head and neck cancer, Breast and other cancers |
| How it works | Stops cancer cells repairing their DNA. | Damages cancer cell DNA so the cells die. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | About 15 hours | About 3–6 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Tablet | IV infusion |
| Common side effects | Nausea, Tiredness, Anaemia, Vomiting, Loss of appetite | Nausea and vomiting, Tiredness, Low blood counts, Hair thinning |
| Serious side effects | Myelodysplastic syndrome or leukaemia (rare), Lung inflammation, Blood clots | Severe low platelets or white cells, Allergic reactions after repeated cycles, Kidney effects |
| Don't take if | Pregnancy; Severe kidney impairment | Severe bone marrow suppression; Allergy to platinum drugs; Pregnancy |
| Alcohol | Best to limit. Alcohol can add to nausea. | Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team. |
| Pregnancy | Usually avoidedAvoid. | Usually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid breastfeeding during treatment. |
| In use since | — | — |
| Brand names | United States: LynparzaUnited Kingdom: LynparzaIndia: Lynparza, Olaparib (generic) | United States: Paraplatin (generic available)United Kingdom: Carboplatin (generic)India: Kemocarb, Carboplatin (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | L01XK01 | L01XA02 |
Taken together
- ModerateOlaparib + Carboplatin: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.